Translate

Tuesday, December 11, 2018

TRUMP ADMINISTRATION HALTS FDA RESEARCH CONTRACT USING "HUMANIZED MICE"

 FDA Contract to Buy Aborted Baby Parts to Breed 'Humanized Mice' 
Terminated After Outrage
 Your Tax Dollars, 'Fresh' Late-term Aborted Babies and Humanized Mice
 TRUMP ADMINISTRATION HALTS RESEARCH CONTRACT USING "HUMANIZED MICE" 
republished below in full unedited for informational, educational and research purposes:
 
The Trump administration recently halted another research contract that used taxpayer dollars to purchase aborted baby body parts.
Pro-life advocates have been putting pressure on the Trump administration to stop funding research projects that use aborted baby parts, and it appears the administration is listening. It canceled a Food and Drug Administration contract in September. Then last week, the administration sent word that it would not renew another.
The National Institutes of Health recently told the University of California San Francisco that it will not renew its $2 million-a-year research contract, according to the Catholic News Agency.
The Orlando Sentinel reports UCSF researchers used aborted baby parts to conduct research on treatments for HIV using “humanized mice.”
According to the report:
Last week, an NIH contracting official told the principal investigator at UCSF that the government was ending the seven-year contract midstream, and that the decision was coming from the “highest levels,” according to a virologist familiar with the events. Five days later, the university received a letter from the AIDS division of NIH’s National Institute for Allergy and Infectious Diseases saying the government would continue the contract for 90 days rather than the expected year-long renewal, with no word of its prospects after that, according to an individual with knowledge of the letter.
A U.S. Department of Health and Human Services Department said no final decisions have been made. But, as the Orlando newspaper reports:
Even so, the principal investigator is preparing to shut down the lab, according to the individual familiar with Monday’s letter from NIH to the university’s business office. The Washington Post is not identifying the investigator, who has been involved with HIV research since the mid-1990s.
To continue reading, click here
[Editor’s Note: The article was written by Micaiah Bilger and published at LifeNews.com]